N-acetyl-l-cystine (NAC) protects against H9N2 swine influenza virus-induced acute lung injury

Zhang, R. H., Li, C. H., Wang, C. L., Xu, M. J., Xu, T., Wei, D., ... & Tian, S. F.

International immunopharmacology 22.1 (2014): 1-8.

The antioxidant N-acetyl-l-cysteine (NAC) had been shown to inhibit replication of seasonal human influenza A viruses. Here, the effects of NAC on H9N2 swine influenza virus-induced acute lung injury (ALI) were investigated in mice. BALB/c mice were inoculated intranasally with 10(7) 50% tissue culture infective doses (TCID(50)) of A/swine/HeBei/012/2008/(H9N2) viruses with or without NAC treatments to induce ALI model. The result showed that pulmonary inflammation, pulmonary edema, MPO activity, total cells, neutrophils, macrophages, TNF-α, IL-6, IL-1β and CXCL-10 in BALF were attenuated by NAC. Moreover, our data showed that NAC significantly inhibited the levels of TLR4 protein and TLR4 mRNA in the lungs. Pharmacological inhibitors of TLR4 (E5564) exerted similar effects like those determined for NAC in H9N2 swine influenza virus-infected mice. These results suggest that antioxidants like NAC represent a potential additional treatment option that could be considered in the case of an influenza A virus pandemic.

N-acetyl-l-cystine-NAC-protects-against-H9N2-swine-influenza-virus-induced-acute-lung-injury

Products Used in this Publication

Catalog NumberCASProduct NamePrice
185955-34-4185955-34-4EritoranInquiry

Related Products

Catalog NumberCASProduct NamePrice
B0001-054910113-73-5Gramicidin SInquiry
B0001-1498097161-73-1Thiocholine iodideInquiry
B0001-16063111096-26-7ErythropoietinInquiry
Price Inquiry